Skip to main content
Figure 4 | Journal of Experimental & Clinical Cancer Research

Figure 4

From: Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer

Figure 4

Tumor inhibition of pGL3-basic-hTERTp-TK-EGFP-CMV/GCV in nude mice with NPC xenograft. Shown are the NPC xenograft in nude mice without treatment (a), injected with GCV and the non-enhanced plasmid (b), injected with GCV and the enhance plasmid (c), injected with GCV(d), injected with Lipofectamine 2000 (e) and injected with the enhance plasmid without GCV (f).

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us